|
⚲
|
| Keyboard |
| Norman Selby | |
|---|---|
| Firm | |
| Address | Tata Innovation Center 11 East Loop Road, Suite 5A New York, NY 10044 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Paigeai Inc | 021-354446 | Director | 71.0 M of 71.0 M |
||
| KEW Group Inc | 021-230541 | Director | 16.8 M of 16.8 M |
||
| KEW Group Inc | 021-211385 | Director | 16.1 M of 30.1 M |
||
| Metamark Genetics Inc | 021-187034 | Director | 9.1 M of 9.1 M |
||
| Infinity Pharmaceuticals Inc | 021-184502 | Director | 78.5 M of 78.5 M |
||
| Perseus Partners VIII Club Fund LP | 021-150970 | Executive Officer | 25.0 M | ||
| Metamark Genetics Inc | 021-144637 | Director | 22.1 M of 42.1 M |
||
| Ascenta Therapeutics Inc | 021-138499 | Director | 1.8 M of 15.0 M |
||
| Nanobio Corp | 021-43468 | Director | 10.0 M | ||